All Posts by Date or last 15, 30, 90 or 180 days.
also by Lloyd: and

Thank you for buying via links and ads on this site,
which earn me advertising fees or commissions.
As an Amazon Associate I earn from qualifying purchases.

Other World Computing...
B&H Photo...
As an Amazon Associate I earn from qualifying purchases.
Get all the tools you need to upgrade the factory HDD of any 2009-2019 iMac to a larger HDD or a modern SSD.
Upgrade the memory of your 2020 iMac up to 128GB

Doctors for COVID Ethics: “Immunology 101: why intramuscular COVID-19 vaccination must fail”


I’m not qualified to assess all of the claims here, and I wonder how this holds up now, 7 months after its May 2021 date?

See also: Jonathan Turley: New York Considers Legislation to Curtail Free Speech in the Name of Democracy

Doctors for COVID Ethis: Immunology 101: why intramuscular COVID-19 vaccination must fail

2021-05-12, by Anonymous, MD,1 Sucharit Bhakdi, MD, and Michael Palmer, MD.

1. Introduction: All antibodies are not created equal

There are different types of antibodies utilized by the human immune system. The major ones are IgM, IgG and IgA [1]; there are two other classes, IgD and IgE, but there is no need to discuss them here.

IgM is generated in the early stages of an adaptive immune response and is then gradually replaced with IgG antibodies. Both IgM and IgG circulate mainly in the bloodstream. IgG is the most abundant antibody in the blood. On the other hand, while some IgA is found in the bloodstream as well, most IgA is secreted across the mucous membranes of the respiratory tract and the gut, which it then covers and protects.


2. Why is sIgA antibody important?

The key reason why an sIgA-based antibody response is desired against respiratory pathogens is that sIgA does not promote inflammation... Since our respiratory tract constantly encounters viruses and bacteria within the air we inhale, IgA-based immune responses help avoid unnecessary and repeated inflammations in our airways. sIgA in the mucous membranes of the respiratory tract can subdue the infection and stop the transmission of these germs safely...

3. What is really damaging our body: viruses, or our own immune system?

Respiratory viruses rarely cause direct damage to our body. It is typically the overreaction of our immune system against those viruses that does the damage [2,3]...

4. The route of vaccination matters

A vaccine that is given by intramuscular (IM) injection will mainly induce IgG antibodies in the blood; this matches the body’s response to pathogens introduced by the same route. It is well known that IM vaccines generate very little or no sIgA in the respiratory tract. Therefore, IM injection is not an efficient way of prepping our immune system against respiratory viruses...

5. An IgG response can be a bad thing

Not only does IgG circulating in the bloodstream fail to prevent infection with respiratory viruses, but an IgG-based immune response can even elicit harmful inflammatory responses, causing serious tissue damage within the respiratory tract. In their recent review article on mucosal immunity to COVID-19, Russell et al. state :

Most attention has been given to virus-neutralizing antibodies, especially circulating antibodies. However, these can only be effective in the prevention of infection or disease if [the antibodies] reach the mucosal surfaces where the virus is present, and it should be noted that circulating IgA, even in polymeric form, is not effectively transported into secretions...

7. Vaccination and Th2-type immunopathology

...It is therefore significant that several experimental vaccines against the original SARS virus, while inhibiting proliferation of the virus within the lungs to some degree, caused Th2-type lung pathology, characterized by increased numbers of eosinophil granulocytes within and aggravated injury to the lungs [15–17]. These results indicate that the experimental vaccines against SARS-CoV may cause more severe illnesses when the vaccinated person is challenged with the real virus... We must stress again that SARS-CoV and SARS-CoV-2 are highly homologous, which means that any risk or problem known with SARS-CoV must be considered with SARS-CoV-2 also. While the manufacturers Pfizer, Moderna, and Johnson & Johnson claim that their vaccines preferentially induce Th1 responses, supporting data from human vaccinees are scarce or lacking altogether 

8. Conclusion

All of the currently used COVID vaccines are applied by intramuscular injection, and they are therefore unable to prevent infection of the upper airways with the SARS-CoV-2 virus. In fact, in their clinical trials, none of the manufacturers even attempted to demonstrate efficacy against infection or transmission in their clinical trials [18–21], and the total lack of efficacy in the real world has since been documented in a large study published by the CDC [22].

The vaccines can, however, lead to severe respiratory immune disease, including Th2-type immunopathology and autoimmunity. When factoring in the large number of adverse events that are being reported with the current vaccines and the low case fatality rate of COVID-19, which we have discussed elsewhere [23], it is clearly more scientific and more reasonable to strive for herd immunity by natural infection rather than vaccination.

WIND: I suppose it all depends on the type of virus. We do have pertussis vaccines after all, that work very well, or so I assume. But it is also abundantly clear that while vaccines appear to have been protective (hospitalization, deaths), they also have led to a massive wave of infections among the vaccinated—a pandemic of the vaccinated.

At the least, the idea that an intra-muscular injection can yield the same quality and type of immune response as an infection is dubious at best. For at least two reasons.

First, the human immune system surely has developed over eons to detect invaders in the airways (nose, mouth, tonsils, lungs, etc). This early warning system is surely highly relevant.

Second, directly injecting an mRNA virus with spike protein gives the body no heads-up from this early warning system; it’s a direct sudden-onset shock to the system.

View all handpicked deals...

Samsung 2TB T7 Shield Portable SSD (Blue)
$250 $200
SAVE $50 | Terms of Use | PRIVACY POLICY
Contact | About Lloyd Chambers | Consulting | Photo Tours
Mailing Lists | RSS Feeds | Twitter
Copyright © 2020 diglloyd Inc, all rights reserved.
Display info: __RETINA_INFO_STATUS__